APA (7th ed.) Citation

Prosty, C., Noutsios, D., Lee, T. C., Daneman, N., Davis, J. S., Jager, N. G., . . . Ong, S. W. (2025). Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis. Clinical Microbiology & Infection, 31(8), 1272. https://doi.org/10.1016/j.cmi.2025.04.045

Chicago Style (17th ed.) Citation

Prosty, Connor, et al. "Cefazolin Vs. Antistaphylococcal Penicillins for the Treatment of Methicillin-susceptible Staphylococcus Aureus Bacteraemia: A Systematic Review and Meta-analysis." Clinical Microbiology & Infection 31, no. 8 (2025): 1272. https://doi.org/10.1016/j.cmi.2025.04.045.

MLA (9th ed.) Citation

Prosty, Connor, et al. "Cefazolin Vs. Antistaphylococcal Penicillins for the Treatment of Methicillin-susceptible Staphylococcus Aureus Bacteraemia: A Systematic Review and Meta-analysis." Clinical Microbiology & Infection, vol. 31, no. 8, 2025, p. 1272, https://doi.org/10.1016/j.cmi.2025.04.045.